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Waardenburg syndrome (WS) is a dominant inherited disorder characterized by pigmentary 
abnormalities of the skin and iris (heterochromia or hypochromia irides) associated with 
sensorial hearing loss and cranio-facial dysmorphisms. Most cases of WS fall into two distinct 
autosomal dominant forms, WS1 and WS2. Dystopia canthorum is present in almost all a ected 
individuals with WS1 and absent in all patients with the WS2 variant. - e prevalence of WS 
(including two other variants rarely found) is estimated in about 1: 40,000; among deaf  
individuals WS is responsible for about three percent of cases in which the deafness is 
congenital. WS1 is caused by PAX3 mutations, while MITF and SOX10 mutations are associated 
with type WS2. All these genes play an important role in the migration and di erentiation of 
melanocytes, pigment-producing cells that originate from the embryonic neural crest. We have 
investigated a sample of 47 WS patients (most are clinically described in Pardono E et al., 
Amer. J. Med. Genet. 117A: 223-235, 2003) with hearing loss, from which 12 were classi ed as 
WS1 and six as WS2, while 29 were isolated cases without telecanthus, very likely a ected by 
WS2. We report six mutations that were found in the PAX3 gene, from which three are novel 
and three had already been reported in the literature; one novel mutation in MITF gene; and 
three novel mutations in the SOX10 gene. Bioinformatic tools indicate that all novel mutations 
we found are probably pathogenic. On the basis of these  ndings, we conclude that molecular 
testing and the exact interpretation of the e ect of mutations found in WS is of signi cant 
importance to genetic counseling, since the probability of developing sensorial hearing loss is 
much higher in WS2 than in WS1. 
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